EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer

Elliott K Yee iD, Julie Hallet, Nicole J Look Hong, Lena Nguyen, Natalie Coburn, Frances C Wright, Sonal Gandhi, Katarzyna J Jerzak, Andrea Eisen, Amanda Roberts

Current Oncology · 2024

DOI: 10.3390/curroncol31080353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Elliott K Yee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Triple Negative Breast Neoplasms, Referral and Consultation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Cancer Society, Sunnybrook AFP Association, Sherif and Mary-Lou Hanna Chair in Surgical Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite consensus guidelines, most patients with early-stage triple-negative (TN) and HER2-positive (HER2+) breast cancer do not see a medical oncologist prior to surgery and do not receive neoadjuvant chemotherapy (NAC). To understand barriers to care, we aimed to characterize the relationship between geography (region of residence and cancer centre proximity) and receipt of a pre-treatment medical oncology consultation and NAC for patients with TN and HER2+ breast cancer. Using linked administrative datasets in Ontario, Canada, we performed a retrospective population-based analysis of women diagnosed with stage I–III TN or HER2+ breast cancer from 2012 to 2020. The outcomes were a pre-treatment medical oncology consultation and the initiation of NAC. We created choropleth maps to assess the distribution of the outcomes and cancer centres across census divisions. To assess the relationship between distance to the nearest cancer centre and outcomes, we performed multivariable regression analyses adjusted for relevant factors, including tumour extent and nodal status. Of 14,647 patients, 29.9% received a pre-treatment medical oncology consultation and 77.7% received NAC. Mapping demonstrated high interregional variability, ranging across census divisions from 12.5% to 64.3% for medical oncology consultation and from 8.8% to 64.3% for NAC. In the full cohort, compared to a distance of ≤5 km from the nearest cancer centre, only 10–25 km was significantly associated with lower odds of NAC (OR 0.83, 95% CI 0.70–0.99). Greater distances were not associated with pre-treatment medical oncology consultation. The interregional variability in medical oncology consultation and NAC for patients with TN and HER2+ breast cancer suggests that regional and/or provider practice patterns underlie discrepancies in the referral for and receipt of NAC. These findings can inform interventions to improve equitable access to NAC for eligible patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyTriple Negative Breast NeoplasmsReferral and ConsultationHumansFemaleMiddle AgedRetrospective StudiesAdultAgedOntarioErb-b2 Receptor Tyrosine KinasesMedical OncologyHealth Services AccessibilityBreast NeoplasmsCancer Care Facilities

Stichwörter der Autor:innen

HER2-positivebreastchemotherapygeographyneoadjuvanttriple-negative

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
  • ICES, Toronto, ON M4N 3M5, Canada.
  • Department of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.

ORCID-Profile: Elliott K Yee

Förderung

  • Canadian Cancer Society
  • Sunnybrook AFP Association
  • Sherif and Mary-Lou Hanna Chair in Surgical Oncology
  • Soloway Chair
  • The Canadian Cancer Society Challenge Grant

Zitieren

APA

Yee, E. K., Hallet, J., Look Hong, N. J., Nguyen, L., Coburn, N., Wright, F. C., Gandhi, S., Jerzak, K. J., Eisen, A., & Roberts, A. (2024). Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer. Current Oncology. https://doi.org/10.3390/curroncol31080353

Vancouver

Yee EK, Hallet J, Look Hong NJ, Nguyen L, Coburn N, Wright FC, et al. Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer. Current Oncology. 2024. doi:10.3390/curroncol31080353

BibTeX
@article{Yee2024,
  author = {Yee, Elliott K and Hallet, Julie and Look Hong, Nicole J and Nguyen, Lena and Coburn, Natalie and Wright, Frances C and Gandhi, Sonal and Jerzak, Katarzyna J and Eisen, Andrea and Roberts, Amanda},
  title = {Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31080353}
}
Kostenlos starten →